0001493152-20-009956.txt : 20200527
0001493152-20-009956.hdr.sgml : 20200527
20200527175953
ACCESSION NUMBER: 0001493152-20-009956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200522
FILED AS OF DATE: 20200527
DATE AS OF CHANGE: 20200527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: David Richard A.
CENTRAL INDEX KEY: 0001812663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 20916454
MAIL ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: SUITE B
CITY: CARLSBAD
STATE: CA
ZIP: 92011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 310-203-1000
MAIL ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
FORMER COMPANY:
FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090402
4
1
ownership.xml
X0306
4
2020-05-22
0
0001460702
Qualigen Therapeutics, Inc.
QLGN
0001812663
David Richard A.
C/O QUALIGEN THERAPEUTICS, INC.,
2042 CORTE DEL NOGAL
CARLSBAD
CA
92011
1
0
0
0
Warrant (Right to Buy)
2.5405
2020-05-22
4
J
0
8857
A
2020-05-22
2027-06-26
Common Stock
8857
8857
D
On May 22, 2020, a reverse merger transaction between the Issuer and Qualigen, Inc. ("Qualigen") was consummated such that Qualigen became a wholly-owned subsidiary of the Issuer (the "Merger"). Pursuant to and effective as of the closing of the Merger (the "Closing"), the Reporting Person became a director of the Issuer.
Immediately prior to the Closing, the Reporting Person held Qualigen Series C convertible preferred stock warrants. Pursuant to the Merger, the Qualigen Series C convertible preferred stock warrants previously held by the Reporting Person were assumed by the Issuer and may be exercised solely for shares of common stock of the Issuer.
/s/ Hayden Trubitt, Attorney-in-Fact for Richard A. David
2020-05-27